[
  {
    "ts": "2026-03-01T08:09:04+00:00",
    "headline": "How The Story Around Ameris Bancorp (ABCB) Is Shifting With New Targets And Buybacks",
    "summary": "Ameris Bancorp’s latest analyst update pegs its fair value price target at US$90.07, up from US$88.83. That shift lines up with recent Street research, where higher targets are increasingly common, even as opinions still split between optimism around earnings catalysts and caution on execution and sector risks. In the sections that follow, you will see how this evolving narrative is taking shape and what to watch if you are tracking Ameris Bancorp. Stay updated as the Fair Value for Ameris...",
    "url": "https://finance.yahoo.com/news/story-around-ameris-bancorp-abcb-080904138.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "68c1319e-c15c-3429-a6b1-a886a909490f",
      "content": {
        "id": "68c1319e-c15c-3429-a6b1-a886a909490f",
        "contentType": "STORY",
        "title": "How The Story Around Ameris Bancorp (ABCB) Is Shifting With New Targets And Buybacks",
        "description": "",
        "summary": "Ameris Bancorp’s latest analyst update pegs its fair value price target at US$90.07, up from US$88.83. That shift lines up with recent Street research, where higher targets are increasingly common, even as opinions still split between optimism around earnings catalysts and caution on execution and sector risks. In the sections that follow, you will see how this evolving narrative is taking shape and what to watch if you are tracking Ameris Bancorp. Stay updated as the Fair Value for Ameris...",
        "pubDate": "2026-03-01T08:09:04Z",
        "displayTime": "2026-03-01T08:09:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/75a6275a0d81fd5fbc47ebecee672e4c",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/GtOHmHb7ARVdAFXcUOUznw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/75a6275a0d81fd5fbc47ebecee672e4c.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CbeCLvAoO9qtHaSiLUwLfg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/75a6275a0d81fd5fbc47ebecee672e4c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/story-around-ameris-bancorp-abcb-080904138.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/story-around-ameris-bancorp-abcb-080904138.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABCB"
            },
            {
              "symbol": "TFC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-03-01T09:23:31+00:00",
    "headline": "Truist Analysts Mixed on EPAM Systems (EPAM) Despite Revenue, Operating Income Beat",
    "summary": "EPAM Systems, Inc. (NYSE:EPAM) is one of the most undervalued AI stocks to buy now. View from Truist analysts remains mixed on EPAM Systems, Inc. (NYSE:EPAM), despite its strong fourth-quarter results, in which both revenue and operating income surpassed analyst expectations. On the positive side, Truist remains confident in the company’s revenue momentum, which it […]",
    "url": "https://finance.yahoo.com/news/truist-analysts-mixed-epam-systems-092331589.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "429cdada-4cd2-3f64-ac71-d9ec620f566b",
      "content": {
        "id": "429cdada-4cd2-3f64-ac71-d9ec620f566b",
        "contentType": "STORY",
        "title": "Truist Analysts Mixed on EPAM Systems (EPAM) Despite Revenue, Operating Income Beat",
        "description": "",
        "summary": "EPAM Systems, Inc. (NYSE:EPAM) is one of the most undervalued AI stocks to buy now. View from Truist analysts remains mixed on EPAM Systems, Inc. (NYSE:EPAM), despite its strong fourth-quarter results, in which both revenue and operating income surpassed analyst expectations. On the positive side, Truist remains confident in the company’s revenue momentum, which it […]",
        "pubDate": "2026-03-01T09:23:31Z",
        "displayTime": "2026-03-01T09:23:31Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/8a9d1ba188a90409bcbe222a12e7c629",
          "originalWidth": 800,
          "originalHeight": 533,
          "caption": "Truist Analysts Mixed on EPAM Systems (EPAM) Despite Revenue, Operating Income Beat",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jHUCy_8imvr111SWmIwuPQ--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/8a9d1ba188a90409bcbe222a12e7c629.cf.webp",
              "width": 800,
              "height": 533,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nK9FRwJeolhiv49rCO1ieA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/8a9d1ba188a90409bcbe222a12e7c629.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/truist-analysts-mixed-epam-systems-092331589.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/truist-analysts-mixed-epam-systems-092331589.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "EPAM"
            },
            {
              "symbol": "TFC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-03-01T15:04:41+00:00",
    "headline": "Truist Raises Target on BILL Holdings (BILL), Keeps Buy Rating",
    "summary": "BILL Holdings, Inc. (NYSE:BILL) is one of the 10 Best Stocks to Buy According to Elliott Investment Management. Truist raised its price target on BILL Holdings, Inc. (NYSE:BILL) from $58 to $59 and keeps a Buy rating on the stock, on February 10, 2026. The new price target and rating reiteration were part of the […]",
    "url": "https://finance.yahoo.com/news/truist-raises-target-bill-holdings-150441604.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "50ac1699-5328-3da0-9bbd-06fcfd84c4f1",
      "content": {
        "id": "50ac1699-5328-3da0-9bbd-06fcfd84c4f1",
        "contentType": "STORY",
        "title": "Truist Raises Target on BILL Holdings (BILL), Keeps Buy Rating",
        "description": "",
        "summary": "BILL Holdings, Inc. (NYSE:BILL) is one of the 10 Best Stocks to Buy According to Elliott Investment Management. Truist raised its price target on BILL Holdings, Inc. (NYSE:BILL) from $58 to $59 and keeps a Buy rating on the stock, on February 10, 2026. The new price target and rating reiteration were part of the […]",
        "pubDate": "2026-03-01T15:04:41Z",
        "displayTime": "2026-03-01T15:04:41Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/94c08ae9c2f011e0b6b8453b5e3ec3a9",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Truist Raises Target on BILL Holdings (BILL), Keeps Buy Rating",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/oWJ5.vjpayfj2jnzkg9sqQ--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/94c08ae9c2f011e0b6b8453b5e3ec3a9.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Xzvhc9I_1m3pyQP4F88H1A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/94c08ae9c2f011e0b6b8453b5e3ec3a9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/truist-raises-target-bill-holdings-150441604.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/truist-raises-target-bill-holdings-150441604.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BILL"
            },
            {
              "symbol": "TFC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-03-01T15:04:38+00:00",
    "headline": "Barclays Upgrades Etsy (ETSY) to Overweight as Truist Raises Target",
    "summary": "Etsy, Inc. (NYSE:ETSY) is one of the 10 Best Stocks to Buy According to Elliott Investment Management. On February 20, 2026, Barclays upgraded its rating on Etsy, Inc. (NYSE:ETSY) from Equal Weight to Overweight with a price target of $72. In the research note, the firm’s analyst noted years of decline in the company and […]",
    "url": "https://finance.yahoo.com/news/barclays-upgrades-etsy-etsy-overweight-150438672.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "6d7fe7e7-8128-3558-acf4-dfb5dab50616",
      "content": {
        "id": "6d7fe7e7-8128-3558-acf4-dfb5dab50616",
        "contentType": "STORY",
        "title": "Barclays Upgrades Etsy (ETSY) to Overweight as Truist Raises Target",
        "description": "",
        "summary": "Etsy, Inc. (NYSE:ETSY) is one of the 10 Best Stocks to Buy According to Elliott Investment Management. On February 20, 2026, Barclays upgraded its rating on Etsy, Inc. (NYSE:ETSY) from Equal Weight to Overweight with a price target of $72. In the research note, the firm’s analyst noted years of decline in the company and […]",
        "pubDate": "2026-03-01T15:04:38Z",
        "displayTime": "2026-03-01T15:04:38Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/383d305f6aa633ef2fff4130172104ed",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Barclays Upgrades Etsy (ETSY) to Overweight as Truist Raises Target",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/C0bjyM.kazmwJgFC69pjRg--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/383d305f6aa633ef2fff4130172104ed.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VB_IljmGixkwrXvEaUua7Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/383d305f6aa633ef2fff4130172104ed.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/barclays-upgrades-etsy-etsy-overweight-150438672.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/barclays-upgrades-etsy-etsy-overweight-150438672.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ETSY"
            },
            {
              "symbol": "TFC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-03-01T14:59:49+00:00",
    "headline": "BeOne Medicines (ONC) Reports $1.5B Revenue for Q4, $1.1B from Lymphoma Treatment",
    "summary": "BeOne Medicines AG (NASDAQ:ONC) is among the 12 best stocks to buy and hold for the next 2 years. On February 26, BeOne Medicines AG (NASDAQ:ONC) reported total global revenues of $1.5 billion for the fourth quarter of 2025 and $5.3 billion for 2026, increases of 33% and 40% from the prior-quarter and prior-year periods, […]",
    "url": "https://finance.yahoo.com/news/beone-medicines-onc-reports-1-145949886.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "2f40c4ca-aa38-368e-bb31-f822d64f9bfe",
      "content": {
        "id": "2f40c4ca-aa38-368e-bb31-f822d64f9bfe",
        "contentType": "STORY",
        "title": "BeOne Medicines (ONC) Reports $1.5B Revenue for Q4, $1.1B from Lymphoma Treatment",
        "description": "",
        "summary": "BeOne Medicines AG (NASDAQ:ONC) is among the 12 best stocks to buy and hold for the next 2 years. On February 26, BeOne Medicines AG (NASDAQ:ONC) reported total global revenues of $1.5 billion for the fourth quarter of 2025 and $5.3 billion for 2026, increases of 33% and 40% from the prior-quarter and prior-year periods, […]",
        "pubDate": "2026-03-01T14:59:49Z",
        "displayTime": "2026-03-01T14:59:49Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/a6b2f83b490c5d8acca468eabb9e72ff",
          "originalWidth": 768,
          "originalHeight": 432,
          "caption": "BeOne Medicines (ONC) Reports $1.5B Revenue for Q4, $1.1B from Lymphoma Treatment",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fJTUrKLwseD9Q5wbV40J4w--~B/aD00MzI7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/a6b2f83b490c5d8acca468eabb9e72ff.cf.webp",
              "width": 768,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jdEmjiWxC9YNR6ggh44O1w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/a6b2f83b490c5d8acca468eabb9e72ff.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/beone-medicines-onc-reports-1-145949886.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/beone-medicines-onc-reports-1-145949886.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ONC"
            },
            {
              "symbol": "TFC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]